Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin A Ezekowitz

Showing results (141-150 of 395) with videos related to

Pageof 40
Sort By:
Current Cardiovascular Risk Reports|June 28, 2021
Feasibility of Incorporating Voice Technology and Virtual Assistants in Cardiovascular Care and Clinical TrialsPishoy Gouda, Elie Ganni, Peter Chung, et al.
American Heart Journal|August 10, 2010
Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) SubstudyJustin A Ezekowitz, Paul W Armstrong, Christopher B Granger, et al.
American Heart Journal|October 12, 2010
Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) TrialMustafa Toma, Yuling Fu, Justin A Ezekowitz, et al.
CMAJ Open|October 13, 2016
The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysisDat T Tran, Arto Ohinmaa, Nguyen X Thanh, et al.
The Canadian Journal of Cardiology|September 2, 2019
Empirical Insights When Defining the Population Burden of Atrial Fibrillation and Oral Anticoagulation Utilization Using Administrative DataNathaniel M Hawkins, Patrick R Daniele, Karin H Humphries, et al.
Echocardiography (Mount Kisco, N.Y.)|October 31, 2018
Impact of contrast echocardiography on accurate discrimination of specific degree of left ventricular systolic dysfunction and comparison with cardiac magnetic resonance imagingAws Alherbish, Harald Becher, Wendimagegn Alemayehu, et al.
BMJ Open|March 19, 2016
Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF)Justin A Ezekowitz, Mohua Podder, Adrian F Hernandez, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 24, 2015
Peripheral chemoreceptor control of cardiovascular function at rest and during exercise in heart failure patientsHeather Edgell, M Sean McMurtry, Mark J Haykowsky, et al.
Annals of Internal Medicine|September 9, 2004
Systematic review: cardiac resynchronization in patients with symptomatic heart failureFinlay A McAlister, Justin A Ezekowitz, Natasha Wiebe, et al.
European Heart Journal. Acute Cardiovascular Care|April 14, 2018
Ambulance use, distance and outcomes in patients with suspected cardiovascular disease: a registry-based geographic information system studyNariman Sepehrvand, Wendimagegn Alemayehu, Padma Kaul, et al.
Pageof 40

Showing results (141-150 of 395) with videos related to

Sort By:
Pageof 40
Current Cardiovascular Risk Reports|June 28, 2021
Feasibility of Incorporating Voice Technology and Virtual Assistants in Cardiovascular Care and Clinical TrialsPishoy Gouda, Elie Ganni, Peter Chung, et al.
American Heart Journal|August 10, 2010
Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) SubstudyJustin A Ezekowitz, Paul W Armstrong, Christopher B Granger, et al.
American Heart Journal|October 12, 2010
Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) TrialMustafa Toma, Yuling Fu, Justin A Ezekowitz, et al.
CMAJ Open|October 13, 2016
The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysisDat T Tran, Arto Ohinmaa, Nguyen X Thanh, et al.
The Canadian Journal of Cardiology|September 2, 2019
Empirical Insights When Defining the Population Burden of Atrial Fibrillation and Oral Anticoagulation Utilization Using Administrative DataNathaniel M Hawkins, Patrick R Daniele, Karin H Humphries, et al.
Echocardiography (Mount Kisco, N.Y.)|October 31, 2018
Impact of contrast echocardiography on accurate discrimination of specific degree of left ventricular systolic dysfunction and comparison with cardiac magnetic resonance imagingAws Alherbish, Harald Becher, Wendimagegn Alemayehu, et al.
BMJ Open|March 19, 2016
Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF)Justin A Ezekowitz, Mohua Podder, Adrian F Hernandez, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 24, 2015
Peripheral chemoreceptor control of cardiovascular function at rest and during exercise in heart failure patientsHeather Edgell, M Sean McMurtry, Mark J Haykowsky, et al.
Annals of Internal Medicine|September 9, 2004
Systematic review: cardiac resynchronization in patients with symptomatic heart failureFinlay A McAlister, Justin A Ezekowitz, Natasha Wiebe, et al.
European Heart Journal. Acute Cardiovascular Care|April 14, 2018
Ambulance use, distance and outcomes in patients with suspected cardiovascular disease: a registry-based geographic information system studyNariman Sepehrvand, Wendimagegn Alemayehu, Padma Kaul, et al.
Pageof 40